|
|
|
| home > epc > autumn 2003 > electronic tools for drug development and registration from a cro's perspective |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
A medium-sized CRO needs to balance their resources carefully in a rapidly changing legal environment. It is vital to have the tools available to serve the needs of both international and national clients and to fine-tune the range of services.
For the core areas of clinical operations, regulatory affairs and data management, different tools are currently available either as software on a license basis or as a service provided by specialised suppliers.
The actual scope, taking the German scenario into account, is:
e-Trials (electronic data capture, e-trial tracking and e-trial management)
Electronic 'AWB' (drug surveillance)
Electronic common technical document (electronic tools for the eCTD)
e-Trials
Electronic data capture has been discussed in numerous articles and meetings for a considerable period of time. The advantages are numerous, the most important, among others, being:
Rapidly available clinical data drives a trial forward with fast decision-making processes
To change the role of the CRA
To avoid the bottleneck for data management in the data cleaning and query resolution prior to database lock
To encourage investigators to complete the electronic case report form quickly and to ease the process of reporting
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Dr Uwe Albrecht, Managing Director of Mediconomics GmbH and Chief Executive Officer of Mediconomics Inc
Dr Uwe W Albrecht started his professional life in 1984 at Behringwerke, Marburg/Lahn where he worked as a CRA on Phase II and Phase III trials in oncology and haematology. By the end of 1987, Dr Albrecht joined Glaxo GmbH, Germany, from which he moved on to Glaxo Group Research Ltd, London, as Senior Clinical Research Scientist in 1990. Moving back to Germany, Dr Albrecht joined Wellcome Germany, mainly focussing on drug development in virology.
In 1993, he was employed at the Institut für Gesundheitsforschung (Institute for Health Research) near Munich as Director of Clinical Research and Regulatory Affairs. From 1995 to 1997, Dr Albrecht worked as Scientific Director with Norgine, Marburg, before joining Pharmakopius International as Head of German Operations. In 1999, he joined Mediconomics GmbH, Hannover as Managing Director.
|
|
|
|
|
|
 |
Industry Events |
 |
BIO-Europe® 2012
12-14 November 2012, Congress Center Hamburg, Hamburg, Germany
Building value through partnerships
BIO-Europe® is the
preeminent partnering conference for the life sciences. BIO-Europe brings
together international decision makers from the biotechnology, pharmaceutical
and financial sectors, offering networking opportunities, workshop and panel
participation, a high profile exhibition, and private, prescheduled one-to-one
meetings.
More info >> |
|
 |
News and Press Releases |
 |
Catalent Case Study Presented On Achieiving Biological Assay Success at IBC’s Biological Assay Development, Validation & Maintenance Conference Workshop
Michael Merges, Director of Biopharmaceutical Support Services, and Michael Sadick, Ph.D., Senior Manager of Biopharmaceutical Characterization, Development and Analytical Services, Catalent Pharma Solutions, will be presenting “Bioassay Development Basics 101,” at the Biological Assay Development, Validation & Maintenance Conference in Boston, MA on Monday, April 30, 2012, at 1:30 PM
More info >> |
|
|
